Skip to content

Innoviva, Inc. INVA Change in AP

Change in AP at other companies

Pfizer logo
PfizerPFE
-$117.25M+54.2%
Merck & Co. logo
Merck & Co.MRK
$27.5M-39.6%
AbbVie logo
AbbVieABBV
-$1.59B-129%
Insmed logo
InsmedINSM
-$33.88M+44.9%
ArriVent BioPharma, Inc. logo
ArriVent BioPharma, Inc.AVBP
$2.81M+382%
Ligand Pharmaceuticals logo
Ligand PharmaceuticalsLGND
$2.71M+226%

Other financials

Income statement

See full
Revenue$98.0M+10.6%
Gross profit$75.8M+3.4%
Operating income$38.2M-7.9%
Net income$186.6M+501%
EPS (diluted)$2.22+400%

Balance sheet

See full
Cash & equivalents$603.1M+89.0%
Total debt$269.4M-40.3%
Total equity$1.3B
Total assets$1.8B+46.4%

Cash flow

See full
Operating cash flow$35.3M-27.4%
CapEx$492.0K
Free cash flow$34.8M-28.4%

Valuation

See full
Market cap$1.74B+51.8%
Enterprise value$1.41B+9.7%
P/E3.5×
P/S4.2×+1.0×

Profitability

See full
Gross margin73.7%-9.9pp
Operating margin38.1%-11.2pp
Net margin119.9%+107pp
FCF margin54.1%+5.3pp

Returns & leverage

See full
Return on equity29.1%
Debt / equity0.2×
Current ratio21.1×+18.7×

Where this comes from

Reported directly by Innoviva, Inc. in its filing.

Tagged under the XBRL concept us-gaap:IncreaseDecreaseInAccountsPayable.

The official record: Innoviva, Inc.’s 10-Q, filed May 6, 2026, on SEC EDGAR. View the filing →

Ask your AI about Innoviva, Inc.'s change in ap.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Innoviva, Inc.'s change in AP?
Innoviva, Inc. (INVA) reported change in AP of $1.55M in Q1 2026.
How has Innoviva, Inc.'s change in AP changed year-over-year?
Innoviva, Inc.'s change in AP decreased by 39.6% year-over-year, from $2.57M to $1.55M.
What does change in AP mean?
Increase or decrease in amounts owed to suppliers — a key working capital component affecting operating cash flow.